Association of oxidative stress on pregnancy
K Toboła-Wróbel, M Pietryga… - Oxidative medicine …, 2020 - Wiley Online Library
The pathophysiological mechanism underlying pregnancy complications such as congenital
malformations, miscarriage, preeclampsia, or fetal growth restriction is not entirely known …
malformations, miscarriage, preeclampsia, or fetal growth restriction is not entirely known …
Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets
Abstract Trisomy of chromosome 21 (TS21) is the most common autosomal aneuploidy
compatible with postnatal survival with a prevalence of 1 in 700 newborns. Its phenotype is …
compatible with postnatal survival with a prevalence of 1 in 700 newborns. Its phenotype is …
Lysosomal dysfunction in Down syndrome is APP-dependent and mediated by APP-βCTF (C99)
Lysosomal failure underlies pathogenesis of numerous congenital neurodegenerative
disorders and is an early and progressive feature of Alzheimer's disease (AD) pathogenesis …
disorders and is an early and progressive feature of Alzheimer's disease (AD) pathogenesis …
Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome
E Lana-Elola, R Aoidi, M Llorian, D Gibbins… - Science translational …, 2024 - science.org
Down syndrome (DS) is caused by trisomy of human chromosome 21 (Hsa21). DS is a gene
dosage disorder that results in multiple phenotypes including congenital heart defects. This …
dosage disorder that results in multiple phenotypes including congenital heart defects. This …
Metformin in therapeutic applications in human diseases: Its mechanism of action and clinical study
Y Du, YJ Zhu, YX Zhou, J Ding, JY Liu - Molecular Biomedicine, 2022 - Springer
Metformin, a biguanide drug, is the most commonly used first-line medication for type 2
diabetes mellites due to its outstanding glucose-lowering ability. After oral administration of …
diabetes mellites due to its outstanding glucose-lowering ability. After oral administration of …
Down syndrome: Neurobiological alterations and therapeutic targets
Down syndrome (DS) is a genetic disease that occurs due to an aneuploidy of human
chromosome 21. Trisomy of chromosome 21 is a primary genetic cause of developmental …
chromosome 21. Trisomy of chromosome 21 is a primary genetic cause of developmental …
[HTML][HTML] The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down …
Mitochondrial dysfunctions critically impair nervous system development and are potentially
involved in the pathogenesis of various neurodevelopmental disorders, including Down …
involved in the pathogenesis of various neurodevelopmental disorders, including Down …
Analysis of microisolated frontal cortex excitatory layer III and V pyramidal neurons reveals a neurodegenerative phenotype in individuals with Down syndrome
MJ Alldred, H Pidikiti, KW Ibrahim, SH Lee… - Acta …, 2024 - Springer
We elucidated the molecular fingerprint of vulnerable excitatory neurons within select
cortical lamina of individuals with Down syndrome (DS) for mechanistic understanding and …
cortical lamina of individuals with Down syndrome (DS) for mechanistic understanding and …
Intranasal administration of kyccsrk peptide rescues brain insulin signaling activation and reduces alzheimer's disease-like neuropathology in a mouse model for …
A Tramutola, S Lanzillotta, G Aceto, S Pagnotta… - Antioxidants, 2023 - mdpi.com
Down syndrome (DS) is the most frequent genetic cause of intellectual disability and is
strongly associated with Alzheimer's disease (AD). Brain insulin resistance greatly …
strongly associated with Alzheimer's disease (AD). Brain insulin resistance greatly …
Down syndrome is a metabolic disease: altered insulin signaling mediates peripheral and brain dysfunctions
M Dierssen, M Fructuoso… - Frontiers in …, 2020 - frontiersin.org
Down syndrome (DS) is the most frequent chromosomal abnormality that causes intellectual
disability, resulting from the presence of an extra complete or segment of chromosome 21 …
disability, resulting from the presence of an extra complete or segment of chromosome 21 …